Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
23 Visningar
• 07/30/23
0
0
Bädda in
administrator
Prenumeranter
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna